Archives of Disease in Childhood
Archives of Disease in Childhood is an international peer review journal that aims to keep paediatricians and others up to date with advances in the diagnosis and treatment of childhood diseases as well as advocacy issues such as child protection. It focuses on all aspects of child health and disease from the perinatal period (in the Fetal and Neonatal edition) through to adolescence. ADC includes original research reports, commentaries, reviews of clinical and policy issues, and evidence reports. Areas covered include: community child health, public health, epidemiology, acute paediatrics, advocacy, and ethics.
The content of Archives of Disease in Childhood is endorsed by the Royal College of Paediatrics and Child Health for Continued Professional Development in line with RCPCH CPD guidelines.
Link to the most recent issue of the journal…
The Drug Therapy section of Archives of Disease in Childhood (ADC) is published in print format every 3 months. The first issue appeared in June 1999. The aim is to include approximately five – six articles, including one editorial, one review and at least 3 original research articles. The aim is to encourage submission of articles from different groups of authors (particularly paediatric clinical pharmacologists and paediatric clinical pharmacists) as well as attracting new readers.
The five most cited articles in 2013 are listed below:
- The pharmacokinetics of intravenous paracetamol in neonates: size matters most (link)
- Propranolol for infantile haemangiomas: a review (link)
- Differences in antibiotic prescribing in paediatric outpatients (link)
- Ciprofloxacin safety in paediatrics: a systematic review (link)
- Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. (link)
These five papers all cover different aspects of paediatric clinical pharmacology which are listed below:
- Drug safety
Members of the ESDPPP are encouraged to submit both original articles and reviews on any aspect of paediatric clinical pharmacology. The main readership of the journal are paediatricians and therefore the clinical message is important. All articles are peer-reviewed and discussed at the editorial board.
ADC is a leading international paediatric journal, which offers authors the option of open access.
Members who wish to consider writing a review article should contact Imti Choonara first (email@example.com)